VRTX

Vertex Pharmaceuticals
VRTX

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$126.96B
EV
$117.48B
Shares Outstanding
258.17M
Beta
0.51

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$500.32
P/E 2025E
27.52x
P/Revenue 2025E
10.60x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Vertex Pharmaceuticals Incorporated

gainify
VRTX

Vertex Pharmaceuticals Incorporated

VRTX

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age or older; SYMDEKO/...

Sector

Healthcare

Industry

Biotechnology

CEO

Kewalramani, Reshma

Employees

6,100

IPO Date

1991-07-24

Headquarters

50 Northern Avenue, Boston, Massachusetts, 02210, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved